THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2) TRIAL: A SINGLE-BLIND RCT OF METOCLOPRAMIDE FOR THE PREVENTION OF PNEUMONIA IN PATIENTS WITH DYSPHAGIA AFTER STROKE

Roffe, C; Bath, P; Warusevitane, A; Smith, C; Dixit, A; Sprigg, N; Helliwell, B; Phillips, N; Sim, J; Jowett, S; Ogollah, R

Christine Roffe c.roffe@keele.ac.uk

P Bath

A Warusevitane

C Smith

A Dixit

N Sprigg

B Helliwell

N Phillips

Julius Sim j.sim@keele.ac.uk

S Jowett

R Ogollah

Presentation Conference Type	Speech
Conference Name	UK Stroke Forum 2021
Conference Location	Virtual
Start Date	Nov 30, 2021
End Date	Dec 2, 2021
Acceptance Date	Oct 1, 2021
Publication Date	Oct 1, 2021
Series Title	UK Stroke Forum 2021
Publisher URL	https://journals.sagepub.com/doi/full/10.1177/17474930211059996